Post-Symptomatic Reversal of Muscle Pathology in a Model of Pompe Disease Using Gene Therapy

被引:0
|
作者
Ramezani, Ali [1 ]
Hordeaux, Juliette [1 ]
Tuske, Steven [2 ]
Song, Chunjuan [1 ]
Mehta, Nickita [2 ]
Tsai, Patrick [2 ]
Weimer, Jill [2 ]
So, Meardey [1 ]
Bell, Peter [1 ]
Do, Hung [2 ]
Wilson, James M. [1 ]
机构
[1] Univ Penn, Gene Therapy Program, Philadelphia, PA 19104 USA
[2] Amicus Therapeut Inc, Gene Therapy Ctr Excellence, Philadelphia, PA USA
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
518
引用
收藏
页码:253 / 253
页数:1
相关论文
共 50 条
  • [31] Current avenues of gene therapy in Pompe disease
    Leon-Astudillo, Carmen
    Trivedi, Prasad D.
    Sun, Ramon C.
    Gentry, Matthew S.
    Fuller, David D.
    Byrne, Barry J.
    Corti, Manuela
    CURRENT OPINION IN NEUROLOGY, 2023, 36 (05) : 464 - 473
  • [32] Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease
    Thurberg, Beth L.
    Maloney, Colleen Lynch
    Vaccaro, Charles
    Afonso, Kendra
    Tsai, Anne Chun-Hui
    Bossen, Edward H.
    Kishnani, Priya S.
    O'Callaghan, Michael
    LABORATORY INVESTIGATION, 2006, 86 (12) : 1208 - 1220
  • [33] AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
    Francesca Gatto
    Barbara Rossi
    Antonietta Tarallo
    Elena Polishchuk
    Roman Polishchuk
    Alessandra Carrella
    Edoardo Nusco
    Filomena Grazia Alvino
    Francesca Iacobellis
    Elvira De Leonibus
    Alberto Auricchio
    Graciana Diez-Roux
    Andrea Ballabio
    Giancarlo Parenti
    Scientific Reports, 7
  • [34] AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
    Gatto, Francesca
    Rossi, Barbara
    Tarallo, Antonietta
    Polishchuk, Elena
    Polishchuk, Roman
    Carrella, Alessandra
    Nusco, Edoardo
    Alvino, Filomena Grazia
    Iacobellis, Francesca
    De Leonibus, Elvira
    Auricchio, Alberto
    Diez-Roux, Graciana
    Ballabio, Andrea
    Parenti, Giancarlo
    SCIENTIFIC REPORTS, 2017, 7
  • [35] Gene Therapy Improves Lifespan and Cardiac Function in a Rat Model of Pompe Disease
    Duncanson, Lauren S.
    Vaught, Lauren A.
    Todd, A. Gary
    Byrne, Barry J.
    Falk, Darin J.
    MOLECULAR THERAPY, 2018, 26 (05) : 300 - 301
  • [36] Reduction of Autophagic Accumulation in Pompe Disease Mouse Model Following Gene Therapy
    McCall, Angela L.
    Stankov, Sylvia G.
    Cowen, Gabrielle
    Cloutier, Denise
    Zhang, Zizhao
    Yang, Lin
    Clement, Nathalie
    Falk, Darin J.
    Byrne, Barry J.
    CURRENT GENE THERAPY, 2019, 19 (03) : 197 - 207
  • [37] Outside the fiber: interstitial pathology of skeletal muscle in infantile Pompe disease
    Ha, Christine I.
    Desai, Ankit K.
    Waterfield, Justin
    Kazi, Zoheb B.
    Austin, Stephanie L.
    Bossen, Edward H.
    Kishnani, Priya S.
    Buckley, Anne F.
    MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S60 - S61
  • [38] Enhanced Efficacy from Gene Therapy in Pompe Disease Using Coreceptor Blockade
    Han, Sang-oh
    Li, Songtao
    Brooks, Elizabeth D.
    Masat, Elisa
    Leborgne, Christian
    Banugaria, Suhrad
    Bird, Andrew
    Mingozzi, Federico
    Waldmann, Herman
    Koeberl, Dwight
    HUMAN GENE THERAPY, 2015, 26 (01) : 26 - 35
  • [39] Salmeterol with Liver Depot Gene Therapy Enhances the Skeletal Muscle Response in Murine Pompe Disease
    Han, Sang-oh
    Li, Songtao
    Everitt, Jeffrey I.
    Koeberl, Dwight D.
    HUMAN GENE THERAPY, 2019, 30 (07) : 855 - 864
  • [40] Immunomodulatory, liver depot gene therapy for Pompe disease
    Bond, J. E.
    Kishnani, P. S.
    Koeberl, D. D.
    CELLULAR IMMUNOLOGY, 2019, 342